High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy

<div>Impact of telbivudine short-time treatment to HBV mutations: (a) the change in HBV quasispecies complexity before and after telbivudine treatment; (b) the change in rtM204I mutation frequency before and after telbivudine treatment.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

fig4

Figure 4

Figure 4: High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy 